Quantcast

Latest Synthetic biology Stories

2014-04-07 11:14:25

UH Math collaborates with Rice on synthetic gene circuit A long-standing challenge in synthetic biology has been to create gene circuits that behave in predictable and robust ways. Mathematical modeling experts from the University of Houston (UH) collaborated with experimental biologists at Rice University to create a synthetic genetic clock that keeps accurate time across a range of temperatures. The findings were published in a recent issue of the Proceedings of the National Academy of...

Functional Designer Chromosome In Yeast Could Lead To Better Biofuels And Medicines
2014-03-28 12:11:24

Lee Rannals for redOrbit.com - Your Universe Online An international team of researchers have taken an important step in the field of synthetic biology, bringing scientists closer to manufacturing microorganisms that could produce biofuels or even medicines. Scientists reported in the journal Science this week that they have synthesized the first functional chromosome in yeast using a computer-aided system. “Our research moves the needle in synthetic biology from theory to...

2014-03-12 08:30:52

Former Endo Health and Johnson & Johnson Executive to Join as Senior Vice President GERMANTOWN, Md., March 12, 2014 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced the appointment of Kelly Huang, Ph.D., most recently President of HealthTronics, Inc., a subsidiary of Endo Health Solutions, to head the Company's newly established Consumer Sector. Dr. Huang will join Intrexon effective March 17, reporting to Chairman and Chief Executive...

2014-03-10 08:30:21

BRIDGEWATER, N.J. and GERMANTOWN, Md., March 10, 2014 /PRNewswire/ -- Amneal Pharmaceuticals LLC, the seventh largest generic drug manufacturer by volume in the U.S., and Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced the formation of an Exclusive Channel Collaboration (ECC) to develop an improved production process for a complex active pharmaceutical ingredient (API). The companies will continue to explore other similar opportunities for...

2014-03-07 08:25:50

GERMANTOWN, Md. and SAN DIEGO, March 7, 2014 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced that it has completed the acquisition of San Diego-based Medistem, Inc. (OTCQB: MEDS), a pioneer in the development of Endometrial Regenerative Cells ("ERC" or "ERCs"), universal donor adult-derived stem cells with properties uniquely suited for therapeutic use with Intrexon's existing suite of synthetic biology technologies. Upon integration of...

2014-03-04 08:32:18

Nir Nimrodi of Thermo Fisher Scientific's Life Technologies Division to join as Senior Vice President GERMANTOWN, Md., March 4, 2014 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced the appointment of Nir Nimrodi, currently Vice President and General Manager of Food Safety and Animal Health at Life Technologies, Inc., now part of Thermo Fisher Scientific, to head Intrexon's Environment Sector, reporting to Chairman and Chief Executive...

2014-02-06 12:28:02

CAMBRIDGE, Mass. and IPSWICH, Mass., Feb. 6, 2014 /PRNewswire/ -- In partnership with the Journal of Visualized Experiments (JoVE), New England Biolabs (NEB(®)) has invited scientists to submit abstracts detailing their unique applications of its Gibson Assembly(®) reagents, for a chance to win a professionally-produced, open-access video publication from JoVE, the most cited, peer-reviewed, video-based journal. (Logo: http://photos.prnewswire.com/prnh/20090921/NE79207LOGO-b)...

2014-02-03 08:28:09

GERMANTOWN, Md., Feb. 3, 2014 /PRNewswire/ -- Intrexon Corporation, (NYSE: XON), a leader in synthetic biology, announced today that Krish Krishnan, Chief Operating Officer of Intrexon, will present at the BIO CEO & Investor Conference on Monday, Feb. 10, at 9:00 a.m. Eastern Standard Time at the Waldorf Astoria in New York. About Intrexon Corporation Intrexon Corporation (NYSE: XON) is a leader in synthetic biology focused on collaborating with companies in Health, Food,...

2014-01-07 16:25:38

GERMANTOWN, Md., Jan. 7, 2014 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, announced today that Randal J. Kirk, Chairman and Chief Executive Officer of Intrexon, will present at the J.P. Morgan Healthcare Conference on Wednesday, January 15, at 1:30 p.m. Pacific Standard Time at the Westin St. Francis in San Francisco. About Intrexon CorporationIntrexon Corporation (NYSE: XON) is a leader in synthetic biology focused on collaborating with companies...

2013-12-30 08:26:20

GERMANTOWN, Md., Dec. 30, 2013 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, announced today that it has entered into a research and development collaboration with Johnson & Johnson Innovation and its affiliate Johnson & Johnson Consumer & Personal Products Worldwide, a division of Johnson & Johnson Consumer Companies, Inc., to advance new skin and hair care products. "We look forward to advancing new skin and hair beauty products...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related